Depression is more widespread than ever in the United States, according to a new study from Gallup, showing that 18% of adults are depressed (or receiving depression treatment for depression) – an increase in 7 percentage points since 2015.
A Danish cohort study has shown a deadly association between depression and rheumatoid arthritis (RA).
Using data from the national Danish rheumatologic database, DANBIO, they identified incident RA patients (between 2008 to 2018) and five random non-RA comparators. Drug use (antidepressants), socioeconomic status, mortality, and cause of death were identified from other registers.
Dr. John Cush RheumNow
3 years 2 months ago
Bringing pivotal clinical trials to you: announcing RheumNow’s Poster Hall, featuring previously presented, sponsor-generated clinical trial posters designed to educate and inform.
https://t.co/2hqKVhtzbv https://t.co/2dTvdU2A9t
Dr. John Cush RheumNow
3 years 2 months ago
Biosimilars Match Biologic Originators in RA
A JAMA review shows that biosimilars of adalimumab, infliximab, and etanercept were associated w/clinically equivalent treatment effects compared with their ref biologics for treatment of RA.
https://t.co/MqxqpzzpiJ https://t.co/Eh98wBUHlj
Dr. John Cush RheumNow
3 years 2 months ago
Time to Risk Stratify Methotrexate Lab Monitoring?
A longitudinal cohort analysis has developed a prognostic model that informs a risk stratified approach to monitoring blood tests during long term methotrexate (MTX) therapy.
https://t.co/lpRhRYg7dd https://t.co/kU2gs3Oljg
Dr. John Cush RheumNow
3 years 2 months ago
Metanalysis of 62 RCTs, 16 LTEs of JAKi, placebo, TNFi, & MTX Rx pts shows that malignancy incidence rate =1.15-1.26/100 Pt-Yrs. Neoplasia risk w/ JAKi = PBO or MTX risk (IRR 0.71 & 0.77); but JAKi CA risk if compared to TNFi (IRR 1.50;1.16 to 1.94) https://t.co/uOgPFlJ2z1 https://t.co/Ynh6SMQdke
Dr. John Cush RheumNow
3 years 2 months ago
#RA pts at increased risk of gastroparesis (GP). From 2012–2014 National Inpatient Sample database; among 1.5 million RA, 1070 hospitalized for GP (OR 1.36; 1.24 to 1.49,P< 0.0001). GP risk incr by aging up to 65 yrs, DM, RA, income 26-75th percentiles https://t.co/2U4vSTtxen https://t.co/ub4z4ntcNk
Combined cranial and large vessel ultrasound and PET/CT provided excellent accuracy for the diagnosis of giant cell arteritis (GCA).
Clinicians treating patients with psoriasis should be on the lookout for certain signs that joint involvement is likely to develop, according to a new "points to consider" documentopens in a new tab or window from the European Alliance of Associations for Rheumatology (EULAR).
Dr. John Cush RheumNow
3 years 2 months ago
TNR- Rheumatoid Arthritis - Decisive Therapeutics
Replay of this RA pod from RheumNow Live 2023, recorded on March 18, 2023
https://t.co/RyyKQFDrT5 https://t.co/ZHjJRzHJ0Q
Dr. John Cush RheumNow
3 years 2 months ago
RheumNow Eular 2023 Daily Recap Series - Day3
June 2, 2023 RheumNow faculty and reporters provide a daily recap of conference content coverage.
https://t.co/4aHy2uJOc6 https://t.co/zOBMX7sgXl
Dr. John Cush RheumNow
3 years 2 months ago
Update on CAR T-Cell Therapy in SLE & Autoimmune Diseases
Dr. Peter Nash ( @drpnash ) reporting from EULAR 2023 in Milan, Italy.
https://t.co/UNXLD5GVKi https://t.co/q8OAexChBN

